Pembrolizumab Favored Over Chemo for Pulmonary AEs

[ad_1]

Researchers look at adverse effects beyond interstitial pneumonitis when comparing antibody monotherapy to chemotherapy in people with non-small cell lung cancer.
Medscape Medical News

[ad_2]

Source link : https://www.medscape.com/viewarticle/monotherapy-linked-lower-pulmonary-aes-beyond-interstitial-2026a1000kg4?src=rss

Author :

Publish date : 2026-06-17 12:57:00

Copyright for syndicated content belongs to the linked Source.

Exit mobile version